Gefitinib Completed Phase 1 Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00027625Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma